echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Japan Pharmaceutical Industry Association (JPMA) delegation visited member enterprises of China Pharmaceutical Promotion Association

    Japan Pharmaceutical Industry Association (JPMA) delegation visited member enterprises of China Pharmaceutical Promotion Association

    • Last Update: 2015-11-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Keisuke Watanabe, deputy of Japan Pharmaceutical Industry Association (JPMA) and senior director of Takeda Pharmaceutical Co., Ltd., November 17-19, 2015 The delegation visited the member enterprises of China pharmaceutical promotion association: Yabao pharmaceutical Beijing Pharmaceutical Research Institute, Institute of pharmaceutical research of Chinese Academy of Medical Sciences, Shanghai Fosun Pharmaceutical Group and Shanghai Pharmaceutical Research Institute of Chinese Academy of Sciences The foreign representatives participating in this activity mainly include: Junichi Matsuzaki, senior researcher of Sino foreign pharmaceutical Co., Ltd., Yoshiyuki Kawakami, director of product innovation Department of Japan Weicai Co., Ltd., Kazuya Fujita, registered senior manager of anstar Pharmaceutical Co., Ltd., Hiroaki Yoshida, director of R & D Department of Japan Pharmaceutical Industry Association Keita Ishibashi, deputy director of Public Relations Department of Takeda Pharmaceutical Industry Co., Ltd and Kiyoshi Horie, director of International Affairs Department of Asahi (Beijing) Pharmaceutical Co., Ltd On the morning of November 17, JPMA delegation visited Beijing Pharmaceutical Research Institute of Yabao Pharmaceutical Co., Ltd president Wang Peng introduced the overall situation, R & D strategy and achievements in innovative pharmaceutical research in recent years of Yabao Pharmaceutical Co., Ltd the two sides had in-depth exchanges and discussions on new drug R & D and technology introduction Representatives of the meeting took photos - Yabao pharmaceutical Beijing Pharmaceutical Research Institute meeting site On the afternoon of November 17, JPMA delegation came to the Institute of pharmaceutical research, Chinese Academy of Medical Sciences Director Jiang Jiandong introduced the general situation of the Research Institute and accompanied the Japanese delegation to visit the national key laboratories such as the National Engineering Laboratory drug screening center Group photo of meeting representatives - representatives from Institute of medicine, Chinese Academy of Medical Sciences visited the laboratory On the morning of November 19, JPMA delegation visited Fosun Pharmaceutical Group, located in Shanghai clone science and technology park Dr Shao Ying, vice president and director of R & D center of Fosun Pharmaceutical Group, introduced the development and R & D status of the group in detail The two sides had fruitful exchanges on the pharmaceutical policy environment of China and Japan and how to strengthen the cooperation of innovative pharmaceutical projects On the afternoon of November 19, JPMA delegation visited the Shanghai Institute of medicine, Chinese Academy of Sciences, located in Zhangjiang High Tech Park, Shanghai Li Jia, deputy director of the Institute, received the delegation and introduced the history, research fields, research progress and the Pharmaceutical Innovation Research Institute under construction to the foreign guests in detail The two sides had in-depth discussions on new drug research and development, scientific and technological transformation and other topics Subsequently, the delegation visited the Institute's drug safety evaluation research center, Shanghai drug metabolism research center, drug target structure and function research center and the national compound sample library Group photo of meeting representatives - Shanghai Institute of pharmaceutical research, Chinese Academy of Sciences The recognition and understanding of the development level of innovative pharmaceutical enterprises in China and the scientific research strength of research institutes have enhanced the interaction between the two associations, which is of great significance to promote the cooperation between China and Japan's pharmaceutical industry and the development of pharmaceutical innovation in Asia Wang Xin, deputy director of CFDA, Lu Xiaoti, deputy director of International Department, and Ruan Xinxin, project manager, participated in the above activities.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.